RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RNXT RenovoRx Inc

Trading 09-28 13:56:35 EDT

1.53

-0.13

-7.83%

High1.65	Low1.50	Vol606.90K
Open1.65	D1 Closing1.66	Amplitude9.04%
Mkt Cap68.93M	Tradable Cap59.93M	Total Shares45.05M
T/O939.30K	T/O Rate1.55%	Tradable Shares39.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":1.53,"timestamp":1790618185906,"preClose":1.66,"halted":0,"volume":606902,"delay":0,"changeRate":-0.07831325301204813,"floatShares":39171100,"shares":45052700,"eps":-0.309615,"marketStatus":"Trading","change":-0.13,"latestTime":"09-28 13:56:35 EDT","open":1.65,"high":1.65,"low":1.5,"amount":939298.2198468,"amplitude":0.090361,"askPrice":1.54,"askSize":600,"bidPrice":1.53,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.309615,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790625600000},"marketStatusCode":2,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":1.66,"preHourTrading":{"tag":"盘前","latestPrice":1.67,"preClose":1.66,"latestTime":"09:00 EDT","volume":3640,"amount":6078.949603999999,"timestamp":1790600434597,"change":0.01,"changeRate":0.006024,"amplitude":0.018072},"postHourTrading":{"tag":"盘后","latestPrice":1.66,"preClose":1.66,"latestTime":"19:58 EDT","volume":296,"amount":495.4551,"timestamp":1790380682297,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.61037},"requestUrl":"/m/hq/s/RNXT/tweets","defaultTab":"tweets","newsList":[{"id":"2664893587","title":"RenovoRx to Present at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664893587","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664893587?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:16","pubTimestamp":1788318993,"startTime":"0","endTime":"0","summary":"RenovoRx to present at H.C. Wainwright Global Investment ConferenceRenovoRx will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York, September 14-16, 2026.CEO Shaun Bagai and CFO Mark Voll are scheduled to present on September 14 at 1:30 p.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5p76xQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662625470","title":"RenovoRx price target raised to $14.50 from $14 at Ascendiant","url":"https://stock-news.laohu8.com/highlight/detail?id=2662625470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662625470?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:55","pubTimestamp":1787914524,"startTime":"0","endTime":"0","summary":"Ascendiant raised the firm’s price target on RenovoRx (RNXT) to $14.50 from $14 and keeps a Buy rating on the shares. The company’s Q2 results show...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovorx-price-target-raised-to-14-50-from-14-at-ascendiant-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovorx-price-target-raised-to-14-50-from-14-at-ascendiant-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732665","title":"RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732665","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732665?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661000,"startTime":"0","endTime":"0","summary":"PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350436/0/en/renovorx-highlights-peer-reviewed-publication-of-pharmacokinetic-and-pharmacodynamic-pk-pd-data-supporting-tamp-platform-s-targeted-drug-delivery-in-locally-advanced-pancreatic-can.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","IDNA","BK4585","IE00B19Z4B17.USD","HYLG","BK4157","IE0031619046.USD","LU1815336091.USD","NVIB","BK4588","MEDX","PD","KBWY","BK4181","BK4183","LU1169589451.USD","IE00B7SZL793.SGD","BK4218","LU0345780281.USD","GDOC","PK","BK4023","LU0345780521.USD","LABU","LU2931357623.SGD","BK4539","ODD","LU0274383776.USD","BK4017","AEIS","IAG","LU1169590202.USD","BK4139","LU0757428866.USD","LU2089985449.USD","IE0009354923.USD","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661933632","title":"RenovoRx regains compliance with Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2661933632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661933632?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:45","pubTimestamp":1787316328,"startTime":"0","endTime":"0","summary":"RenovoRx (RNXT) announced that it has received written notification from Nasdaq confirming that the company has regained compliance with the minimu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovorx-regains-compliance-with-nasdaq-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovorx-regains-compliance-with-nasdaq-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4139","LCLG","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661985302","title":"RenovoRx Regains Compliance with NASDAQ Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661985302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661985302?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:30","pubTimestamp":1787315400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nTUA8QPZG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661532212","title":"RenovoRx Earnings Call: Record Growth, Rising Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2661532212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661532212?lang=en_us&edition=fundamental","pubTime":"2026-08-21 08:27","pubTimestamp":1787272045,"startTime":"0","endTime":"0","summary":"Renovorx, Inc. (($RNXT)) has held its Q2 earnings call. Read on for the main highlights of the call. RenovoRx’s latest earnings call struck a cauti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renovorx-earnings-call-record-growth-rising-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renovorx-earnings-call-record-growth-rising-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661010234","title":"RenovoRx Regains NASDAQ Compliance with $1 Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2661010234","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661010234?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:07","pubTimestamp":1787256431,"startTime":"0","endTime":"0","summary":"RenovoRx regains Nasdaq compliance with $1 minimum bid price ruleRenovoRx regained Nasdaq compliance with the $1 minimum bid price rule, removing a key listing-risk overhang.Nasdaq confirmed the stock closed at $1 or higher for 10 straight sessions from Aug. 6, 2026 through Aug. 19, 2026.The company had received a deficiency notice on Dec. 31, 2025 following 30 consecutive business days below $1.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL3LsW9s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660284179","title":"RenovoRx Gets USPTO Notice of Allowance for New RenovoCath Cancer Drug-Delivery Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2660284179","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660284179?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:31","pubTimestamp":1787229099,"startTime":"0","endTime":"0","summary":"RenovoRx gets USPTO notice of allowance for new RenovoCath cancer drug-delivery patentRenovoRx received a USPTO notice of allowance for a new US patent application covering its RenovoCath dual-occlusi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL8z11Mn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","SG9999014005.SGD","RNXT","NDAQ","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660284180","title":"RenovoRx - Receives Uspto Notice of Allowance for Renovocath Patent Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2660284180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660284180?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:31","pubTimestamp":1787229070,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0J6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660510427","title":"Analyst Justin Walsh Reiterates Buy on RenovoRx After Strong 2Q26 Beat, Guidance Raise and Confirms $8 Price Target on TAMP Platform Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2660510427","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660510427?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:35","pubTimestamp":1787160926,"startTime":"0","endTime":"0","summary":"RenovoRx, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Walsh from JonesTrading reiterated a Buy rati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-justin-walsh-reiterates-buy-on-renovorx-after-strong-2q26-beat-guidance-raise-and-confirms-8-price-target-on-tamp-platform-momentum-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-justin-walsh-reiterates-buy-on-renovorx-after-strong-2q26-beat-guidance-raise-and-confirms-8-price-target-on-tamp-platform-momentum-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659912609","title":"Cancer Diagnostics Firm Precipio's Q2 Revenue Rises, Adjusted Ebitda Turns Positive","url":"https://stock-news.laohu8.com/highlight/detail?id=2659912609","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659912609?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:10","pubTimestamp":1786738233,"startTime":"0","endTime":"0","summary":"Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positiveOverviewUS specialty cancer diagnostics firm's Q2 revenue rose 22% yr/yr to $7.0 mlnAdjusted EBITDA improved to $0.4 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0VE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4539","AKTS","PRPO","RNXT","BK4139","BK4568","BK4148","BK4082","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659463741","title":"Milestone Scientific Q2 Revenue Rises 22% on Medical Segment Growth, Reaffirms 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659463741","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659463741?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:42","pubTimestamp":1786707736,"startTime":"0","endTime":"0","summary":"Milestone Scientific Q2 revenue rises 22% on medical segment growth, reaffirms 2026 outlookOverviewMedical device maker's Q2 revenue rose 22% yr/yr, driven by dental and medical segment growthMedical ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","RNXT","BK4539","MLSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659116741","title":"Sensus Healthcare Q2 Revenue Misses Estimates as Unit Sales Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2659116741","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659116741?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:31","pubTimestamp":1786653086,"startTime":"0","endTime":"0","summary":"Sensus Healthcare Q2 revenue misses estimates as unit sales fallOverviewU.S. medical device maker's Q2 revenue fell sharply and missed analyst expectationsAdjusted EBITDA loss widened yr/yr, reflectin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRTS","BK4082","RNXT","BK4139","BK4539","ATRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167860","title":"CapsoVision Q2 Revenue Rises on CapsoCam Plus Capsules Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167860","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167860?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:17","pubTimestamp":1786652227,"startTime":"0","endTime":"0","summary":"CapsoVision Q2 revenue rises on CapsoCam Plus capsules salesOverviewUS capsule endoscopy firm's Q2 revenue rose 10% yr/yr to $3.6 mlnGross margin declined to 51% from 55% due to pricing pressure and h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A14S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CV","BK4139","RNXT","BK4082","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659028162","title":"Tenon Medical Q2 Revenue Jumps on Higher Surgical Procedure Volume","url":"https://stock-news.laohu8.com/highlight/detail?id=2659028162","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659028162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652143,"startTime":"0","endTime":"0","summary":"Tenon Medical Q2 revenue jumps on higher surgical procedure volumeOverviewUS medical device maker's Q2 revenue rose 127% yr/yr on higher surgical procedure volumeQ2 gross profit up 232% yr/yr, gross m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A14N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","BK4539","BK4198","BK4082","RNXT","TELA","XTNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151392","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151392","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151392?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:40","pubTimestamp":1786621235,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on OptimizeRx (OPRX) and RenovoRx (RNXT) with bullish s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-298?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-298?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT","BK4539","BK4139","OPRX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659562311","title":"Beyond Air Q1 Net Loss Slightly Widens, Reaffirms 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659562311","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659562311?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:13","pubTimestamp":1786619594,"startTime":"0","endTime":"0","summary":"Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlookOverviewUS medical device maker's Q1 revenue was flat yr/yr at $1.8 mlnCompany completed up to $30.1 mln financing to support commercial e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VREX","EYES","BK4082","BK4157","TDY","BK4585","BZZ","RNXT","BK4588","BK4007","LU0251142724.SGD","LU0048573561.USD","BK4564","LU0251131958.USD","XAIR","BK4539","LU0742534661.SGD","BK4139","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659113378","title":"Sweden's RaySearch Q2 Order Intake Rises on Clinical Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2659113378","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659113378?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:42","pubTimestamp":1786599764,"startTime":"0","endTime":"0","summary":"Sweden's RaySearch Q2 order intake rises on clinical adoptionOverviewSweden oncology software firm's Q2 net sales fell 11% yr/yr, organic growth at -8%Adjusted EPS for Q2 declined to SEK 0.57 from SEK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A06H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","KURA","BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659868041","title":"RenovoRx Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659868041","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659868041?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:25","pubTimestamp":1786573545,"startTime":"0","endTime":"0","summary":"RenovoRx Inc reports results for the quarter ended June 30 - Earnings SummaryRenovoRx IncRNXT.OQreported a quarterly adjusted loss of 5 cents per share for the quarter ended June 30, higher than the s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4492B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900195","title":"Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900195","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900195?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:20","pubTimestamp":1786566051,"startTime":"0","endTime":"0","summary":"Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlookOverviewTargeted oncology device maker's Q2 2026 revenue rose 115% yr/yr to record $909,000Company raised full-year 2026 revenue gu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44911Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4588","LEGN","IMNM","ICCM","MEDI","BK4585","BK4539","RNXT","BK4505","BK4139","BK4082","CANC","MEMS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renovorx.com;renovorx.com","stockEarnings":[{"period":"1week","weight":-0.0178},{"period":"1month","weight":0.1141},{"period":"3month","weight":0.759},{"period":"6month","weight":0.469},{"period":"1year","weight":0.4188},{"period":"ytd","weight":0.976}],"compareEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":0.0069},{"period":"3month","weight":0.0581},{"period":"6month","weight":0.2165},{"period":"1year","weight":0.1722},{"period":"ytd","weight":0.1311}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.049533},{"month":2,"riseRate":0.6,"avgChangeRate":0.102207},{"month":3,"riseRate":0.2,"avgChangeRate":-0.093103},{"month":4,"riseRate":0,"avgChangeRate":-0.163527},{"month":5,"riseRate":0.6,"avgChangeRate":0.050959},{"month":6,"riseRate":0.6,"avgChangeRate":0.043263},{"month":7,"riseRate":0.2,"avgChangeRate":-0.031811},{"month":8,"riseRate":0.4,"avgChangeRate":0.107266},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.065044},{"month":10,"riseRate":0,"avgChangeRate":-0.120676},{"month":11,"riseRate":0.6,"avgChangeRate":0.028303},{"month":12,"riseRate":0.6,"avgChangeRate":0.479671}],"exchange":"NASDAQ","name":"RenovoRx Inc","nameEN":"RenovoRx Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest RenovoRx Inc(RNXT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"RenovoRx Inc,RNXT,RenovoRx Inc股票,RenovoRx Inc股票老虎,RenovoRx Inc股票老虎国际,RenovoRx Inc行情,RenovoRx Inc股票行情,RenovoRx Inc股价,RenovoRx Inc股市,RenovoRx Inc股票价格,RenovoRx Inc股票交易,RenovoRx Inc股票购买,RenovoRx Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest RenovoRx Inc(RNXT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction